首页|《布鲁氏菌病诊疗方案(2023年版)》解读

《布鲁氏菌病诊疗方案(2023年版)》解读

扫码查看
布鲁氏菌病(brucellosis),简称布病,是由布鲁氏菌(Brucella)感染引起的人畜共患疾病,属于我国规定的乙类传染病.近些年来我国布病发病率持续上升,本文通过对国家卫生健康委办公厅颁发的《布鲁氏菌病诊疗方案(2023年版)》中更新内容及要点进行解读,以供临床医生在实际工作中参考,提高布病诊治能力,降低病死率.
Interpretation of Diagnosis and Treatment Plan for Brucellosis(2023 Edition)
Brucellosis is a zoonotic disease caused by Brucella infection and belongs to the legal category B infectious diseases in our country.The incidence of brucellosis has continued to rise in recent years domestically.The paper analyzed the updated contents and key points of the Diagnosis and Treatment Guidelines for Brucellosis(2023 Edition)issued by the National Health Commission so as to provide reference for clinicians in practical work,improve the diagnosis and treatment ability of brucellosis and reduce the mortality rate.

BrucellosisDiagnosisTreatmentInterpretation

李晓冉、曲俊彦

展开 >

四川大学华西医院感染性疾病中心,成都 610041

布鲁氏菌病 诊断 治疗 解读

2024

中国抗生素杂志
中国医药集团总公司四川抗菌素工业研究所,中国医学科学院医药生物技术研究所

中国抗生素杂志

CSTPCD北大核心
影响因子:1.08
ISSN:1001-8689
年,卷(期):2024.49(7)
  • 5